登录    
  
首页 > 期刊论文 > 论文摘要
UHRF1基因沉默对逆转人肺腺癌A549细胞顺铂耐药性的影响
         
Reverse effect of UHRF1 gene silencing on cisplatin resistance of lung adenocarcinoma A549 cells

摘    要
目的: 检测泛素样含PHD和环指域1(ubiquitin-like with PHD and ringfinger domain 1,UHRF1)基因在人肺腺癌顺铂(cisplatin,DDP)耐药细胞株A549/DDP及其亲本细胞株A549中的表达差异,并探讨沉默UHRF1基因对逆转A549/DDP细胞对DDP耐药性的影响。
方法: 采用半定量RT-PCR和蛋白质印迹法检测UHRF1 mRNA和蛋白在A549及A549/DDP细胞中的表达差异。随后构建靶向沉默UHRF1基因的短发夹RNA(short hairpin RNA,shRNA)质粒表达载体,并采用慢病毒感染法感染至A549/DDP细胞,同时设未进行感染的空白对照组和感染非特异性shRNA的阴性对照组。采用蛋白质印迹法检测各组细胞中UHRF1蛋白的表达水平。采用MTT法检测各组细胞在DDP作用下的半数抑制浓度(half maximal inhibitory concentration,IC50)。采用FCM法检测细胞凋亡率。采用蛋白质印迹法检测凋亡调节因子Bcl-2和Bax的表达情况。
结果: UHRF1 mRNA和蛋白在A549/DDP细胞中的表达水平显著高于亲代A549细胞(P<0.01)。靶向UHRF1基因的shRNA明显下调A549/DDP细胞中UHRF1蛋白的表达水平(P<0.01)。在不同浓度DDP作用24 h后,UHRF1-shRNA组A549/DDP细胞的IC50值明显低于空白对照组和阴性对照组,对DDP的敏感性显著提高(P值均<0.01)。DDP(6 mg/L)作用24 h后,UHRF1-shRNA组细胞的凋亡率及促凋亡蛋白Bax的表达水平较空白对照组和阴性对照组明显增高,而抗凋亡蛋白Bcl-2的表达水平则明显下调(P值均<0.01)。
结论: UHRF1基因在人耐药肺腺癌细胞中呈现高表达,提示UHRF1参与肺腺癌耐药的形成; UHRF1-shRNA可特异性下调UHRF1的表达,逆转A549/DDP细胞对DDP的耐药性,并通过调节凋亡相关基因的表达促进其凋亡。UHRF1基因可能成为逆转肺癌耐药性的一个新的分子靶点。
标    签 癌,非小细胞肺   抗药性   RNA干扰   UHRF1基因   Carcinoma, non-small cell lung   Drug resistance   RNA interfering   UHRF1 gene  
 
Abstract
Objective: To examine the ubiquitin-like with PHD and ringfinger domain 1(UHRF1) gene expression in cisplatin (DDP)-resistant lung adenocarcinoma A549/DDP cells and parental A549 cells, and to investigate the reverse effect of UHRF1 gene silencing on DDP resistance of A549/DDP cells.
Methods: The expression levels of UHRF1 mRNA and protein in A549 and A549/DDP cells were dectected by RT-PCR and Western blotting, respectively. The UHRF1-short hairpin RNA (shRNA) expression plasmid vectors were constructed and infected into A549/DDP cells by lentiviral infection approach. The A549/DDP cells infected with lentivirus containing negative control shRNA (NC-shRNA) or not were as the negative control and the blank control, respectively. The expression level of UHRF1 protein in each group was evaluated by Western blotting. The half maximal inhibitory concentration (IC50) of DDP was examined by MTT assay. The apoptosis rate was determined by flow cytometry (FCM). The protein expression levels of apoptosis regulatory factors Bcl-2 and Bax were detected by Western blotting.
Results: The expression levels of UHRF1 mRNA and protein in A549/DDP cells were significantly elevated as compared with those of parental A549 cells (P < 0.01). The shRNA targeting UHRF1 gene could down-regulate the protein expression of UHRF1 in A549/DDP cells (P < 0.01). After treatment with different concentrations of DDP for 24 h, the IC50 of DDP in UHRF1-shRNA group was significantly decreased, as compared with those in the negative control and the blank control groups (both P < 0.01). After treatment with DDP (6 mg/L) for 24 h, the apoptosis rate and the expression of proapoptotic protein Bax in UHRF1-shRNA group were significantly increased, but the expression of antiapoptotic protein Bcl-2 was significantly decreased, as compared with those in the negative control and the blank control groups (all P < 0.01).
Conclusion: The over-expression of UHRF1 in DDP-resistant human lung adenocarcinoma cells suggests that UHRF1 might be involved in the chemoresistance of lung cancer. UHRF1-specific shRNA can down-regulate the expression of UHRF1, reverse the resistance to DDP in A549/DDP cells, and promote apoptosis through influencing the expressions of apoptosis regulatory factors. UHRF1 may be a new target for reversal of chemoresistance of lung cancer.

中图分类号 R734.2   DOI 10.3781/j.issn.1000-7431.2015.11.381

 
  购买该论文  中国光学期刊网论文下载说明
      


所属栏目 基础研究

基金项目 河北省医学科学研究重点课题计划资助项目(编号:ZL20140104)

收稿日期 2015/5/18

修改稿日期 2015/7/2

网络出版日期

作者单位点击查看


引用该论文: YANG Congrong,ZHAO Xuetao,WANG Jun,WU Fengpeng,BIAN Chenfeng. Reverse effect of UHRF1 gene silencing on cisplatin resistance of lung adenocarcinoma A549 cells[J]. Tumor, 2015, 35(8): 834~841
杨从容,赵学涛,王军,吴凤鹏,边晨峰. UHRF1基因沉默对逆转人肺腺癌A549细胞顺铂耐药性的影响[J]. 肿瘤, 2015, 35(8): 834~841


论文评价
共有人对该论文发表了看法,其中:
人认为该论文很差
人认为该论文较差
人认为该论文一般
人认为该论文较好
人认为该论文很好
分享论文
分享到新浪微博 分享到腾讯微博 分享到人人网 分享到 Google Reader 分享到百度搜藏分享到Twitter

参考文献
【1】Hoffillan PC, Mauer AM, Vokes EE. Lung cancer[J]. Lancet, 2000, 355(9202):479-485.
 
【2】Pignon JP, Tribodet H, Seagliotti GV, et al. Lung adjuvant cisPlatin evaluation:a pooled analysis by the LACE Collaborative Group[J]. J Clin Oncol, 2008, 26(21):355-3559.
 
【3】Bria E, CuPPone F, Cecere FL, et al. Adjuvant chemotherapy for non-small cell lung cancer[J]. J Thorae Oneol, 2007, 2(SuPPI):S7-11.
 
【4】Bronner C, Achour M, Arima Y, et al. The UHRF family:oncogenes that are drugable targets for cancer therapy in the near future?[J]. Pharmacol Ther, 2007, 115(3):419-434.
 
【5】Qin Y, Wang J, Gong W, et al. UHRF1 depletion suppresses growth of gallbladder cancer cells through induction of apoptosis and cell cycle arrest[J]. Oncol Rep, 2014, 31(6):2635-2643.
 
【6】Tian Y, Paramasivam M, Ghosal G, et al. UHRF1 contributes to DNA damage repair as a lesion recognition factor and nuclease scaffold[J]. Cell Rep, 2015, 10(12):1957-1966.
 
【7】Kim KB, Son HJ, Choi S, et al. H3K9 methyltransferase G9a negatively regulates UHRF1 transcription during leukemia cell differentiation[J]. Nucleic Acids Res, 2015, 43(7):3509-3523.
 
【8】Pi JT, Lin Y, Quan Q, et al. Overexpression of UHRF1 is significantly associated with poor prognosis in laryngeal squamous cell carcinoma[J]. Med Oncol, 2013, 30(4):613.
 
【9】Yan F, Shao LJ, Hu XY, et al. Knockdown of UHRF1 by lentivirus-mediated shRNA inhibits ovarian cancer cell growth[J]. Asian Pac J Cancer Prev, 2015, 16(4):1343-1348.
 
【10】Unoki M, Daigo Y, Koinuma J, et al. UHRF1 is a novel diagnostic marker of lung cancer[J]. Br J Cancer, 2010, 103(2):217-222.
 
【11】Unoki M, Kelly JD, Neal DE, et al. UHRFl is a novel molecular marker for diagnosis and the prognosis of bladder cancer[J].Br J Cancer, 2009, 101(1):98-105.
 
【12】Yang C, Wang Y, Zhang F, et al. Inhibiting UHRF1 expression enhances radiosensitivity in human esophageal squamous cell carcinoma[J]. Mol Biol Rep, 2013, 40(9):5225-5235.
 
【13】杨从容, 王雅棣, 景绍武, 等. RNA干扰UHRF1基因表达对食管癌细胞生物学行为的影响[J]. 肿瘤, 2013, 33(5):392-397.
 
【14】Zhang Y, Huang Z, Zhu Z, et al. Upregulated UHRF1 promotes bladder cancer cell invasion by epigenetic silencing of KiSS1[J]. PLoS One, 2014, 9(10):e104252.
 
【15】Zhou L, Zhao X, Han Y, et al. Regulation of UHRF1 by miR-146a/b modulates gastric cancer invasion and metastasis[J]. FASEB J, 2013, 27(12):4929-4939.
 
【16】Li XL, Xu JH, Nie JH, et al. Exogenous expression of UHRF1 promotes proliferation and metastasis of breast cancer cells[J]. Oncol Rep, 2012, 28(1):375-383.
 
【17】Wang F, Yang YZ, Shi CZ, et al. UHRF1 promotes cell growth and metastasis through repression of p16(ink4a) in colorectal cancer[J]. Ann Surg Oncol, 2012, 19(8):2753-2762.
 
【18】Ying L, Lin J, Qiu F, et al. Epigenetic repression of regulator of G-protein signaling 2 by ubiquitin-like with PHD and ring-finger domain 1 promotes bladder cancer progression[J]. FEBS J, 2015, 282(1):174-182.
 
相关信息
   标题 相关频次
 UHRF1基因沉默可促进人肺腺癌A549细胞的凋亡
 13
 H2O2氧化刺激对紫杉醇耐药和敏感肺癌细胞的不同影响
 6
 上皮-间质转化和胰岛素样生长因子Ⅰ型受体在非小细胞肺癌EGFR-TKIs获得性耐药中的作用
 6
 GRIM-19基因对肺腺癌耐药细胞株A549/DDP药物敏感性及相关基因表达的影响
 4
 Luffin-β靶向融合免疫毒素的构建、表达及对非小细胞肺癌的抑制作用
 4
 单药培美曲塞二线治疗晚期非小细胞肺癌的疗效观察
 4
 非小细胞肺癌组织中血管内皮生长因子表达与树突状细胞分布的关系
 4
 高海拔地区老年非小细胞肺癌患者接受全电视胸腔镜下肺叶切除的安全性和预后分析
 4
 化疗序贯厄洛替尼治疗二线厄洛替尼耐药晚期非小细胞肺癌的临床疗效和安全性
 4
 人肺腺癌细胞株A549和A549/DDP的比较蛋白质组学研究
 4
 重组人血管内皮抑制素联合含铂方案治疗晚期非小细胞肺癌的临床观察
 4
 RNA干扰UHRF1基因表达对食管癌细胞生物学行为的影响
 3
 RNA干扰抑制Apollon表达联合川芎嗪可增强白血病细胞对化疗药物的敏感性
 3
 靶向ABCG2基因的RNA干扰提高K562细胞的化疗敏感性
 3
 多靶点受体酪氨酸激酶抑制剂联合化疗治疗晚期非小细胞肺癌的Meta分析
 3
 反转录病毒介导的HPV16 E6-siRNA对SiHa细胞增殖及抗药性的影响
 3
 非小细胞肺癌CD44v6表达的免疫组化研究
 3
 血管内皮生长因子C过表达或抑制表达对人小细胞肺癌NCI-H446细胞生物学行为的影响
 3
 ABCC8、CHFRBMP3BLOXPRSS21和RASSF1A基因启动子的甲基化状态可能与3种乳腺癌细胞株对5-FU的敏感性相关
 2
 RMP基因沉默对肝癌SMMC-7721细胞增殖和迁移能力的影响
 2
 2009年恶性肿瘤临床治疗新进展
 2
 34例卵巢透明细胞癌临床分析
 2
 Autotaxin在人卵巢癌基因及蛋白水平表达的研究及意义
 2
 C-myc蛋白在睾丸肿瘤中的表达及意义
 2
 cRGD-氧化铁纳米粒的构建及应用于核磁共振成像诊断中的动物研究
 2
 HL-60及其耐药细胞之间线粒体膜及线粒体中Bid差异研究
 2
 Livin在人脑星形细胞瘤中的表达及意义
 2
 RNA干扰UHRF1基因表达对食管癌细胞生物学行为的影响
 2
 癌症的远古性及其理论和实践意义
 2
 膀胱移行细胞癌中cPKCα的表达及意义
 2

  热点专题


关于我们  |   联系我们  |   广告投放  |   《肿瘤》杂志社版权所有 《肿瘤》杂志社   © 中国 上海 2014.3
沪ICP备15036656号-2